VAERS Explorer
Back to explore

Report #2851378

Received Jul 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
16 yrs
State
IA
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK9N2R2—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

A 16 years old male patient received a dose of Shingrix.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-year-old male patient who received Herpes zoster (Shingrix) (batch number 9N2R2, expiry date 25-APR-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate age at vaccine administration (Verbatim: A 16 years old male patient received a dose of Shingrix.). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 22-JUL-2025 The clinic administrator reported that they administered a dose of Shingrix to a 16 year old patient, which led to inappropriate age at vaccine administration. The reporter asked that there were any long-term side effects for the patient and there was any safety information available.